Argutus Medical, a developer of specialised organ injury tests, and a subsidiary of EKF Diagnostics, has introduced RenaStat, its new point-of-care (POC) test.RenaStat was specifically developed to detect the early onset of severe acute kidney injury (AKI) in critical care settings.
The Argutus team can also provide scientific information on the development and use of biomarkers for AKI detection.
www.argutusmed.com
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
ACV, Vienna, Austria
6 -10 September, 2025
The International Convention Centre (ICC), Birmingham
22-25 September, 2025
The Catalyst, Newcastle
3 October
Manchester Conference Centre
8 October
Online
11-13 November, 2025
